The ROC curve and the AUC value (0.7575) show that CX3CL1/ADAM17 ratio as a biomarker has a moderate predictive ability to discriminate IPF from OFI (Figure 6). The gene discussed is ADAM17; the disease is idiopathic pulmonary fibrosis.